• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Dendreon Corp

+ Add to Watchlist


0.058 EUR 0.011 15.94%

As of 02:17:27 ET on 12/29/2014.

Snapshot for Dendreon Corp (DNR)

Open: 0.058 Day's Range: 0.058 - 0.058 Volume: 2,000
Previous Close: 0.069 52wk Range: 0.052 - 2.538 1-Yr Rtn: -97.50%

Stock Chart for DNR

No chart data available.
  • DNR:GR 0.058
  • 1D
  • 1M
  • 1Y
Interactive DNR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DNR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 9.21
Shares Outstanding (M) 158.72
30 Day Average Volume 48,908
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DNR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DNR

Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer. The Company combines knowledge in immunology and antigen engineering with proprietary cell separation technologies to develop therapeutic vaccines that induce cell-mediated immunity, the body's key defense against cancer.

Douglas G Watson "Doug"ChairmanW Thomas Amick "Tom"President/CEO
Andrew S SandlerExec VP/Chief Medical OfficerGregory R CoxInterim CFO/VP:Finance
More Company Profile & Key Executives for DNR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil